BioCina

A global CDMO offering top-tier quality, regulatory compliance and industry-leading on-time delivery, BioCina brings expertise in small molecules, microbial systems, pDNA and mRNA, providing cell line development, process development, analytics, formulation and cGMP manufacturing. Operating facilities in Adelaide and Perth with a strong regulatory record of approvals from the US FDA, EMA, Health Canada and TGA, BioCina serves global clients with a manufacturing-only focus, supported by Australia's tax incentives of up to 48.5% cash refund for drug developers.